Call Us Today! (732) 701-7807|info@ozmosi.com
FacebookTwitterLinkedIn

forecast model

Pharma Forecasting Case Study – Shaping R&D Strategy

2017-07-18T20:13:13+00:00

The oncology team of a major multinational pharmaceutical company asked Ozmosi to provide additional forecasting support for a newly acquired product. They needed to update and validate the current forecast models to identify the most effective development strategies for the compound across all indications. The team was concerned with how to get their product to the most critical patients and wanted to explore strategies to maximize market share and minimize losses to cannibalization. Ozmosi provided global forecasts for multiple indications across multiple products, assessing the value impact of multiple development scenarios. The scenarios we developed considered the effects of differences in [...]

Pharma Forecasting Case Study – Shaping R&D Strategy2017-07-18T20:13:13+00:00

PHARMA FORECASTING CASE STUDY – Estimating the Prevalence of Orphan Diseases

2017-07-18T19:40:24+00:00

When in-house experts’ forecasts for the market potential of a treatment for an orphan disease conflicted, the management team at a large, multinational pharmaceutical company turned to Ozmosi to resolve the differences. Addressing the central questions required a full literature review, including analysis of more than 30 individual studies released between the 1990s and 2013, as well as physician surveys, internal studies, advisory board results, and other sources. We also conducted in-depth interviews with the company’s two in-house epidemiology experts working on the project. Projections were complicated by the fact that the disease, which affects fewer than 10 people per million, [...]

PHARMA FORECASTING CASE STUDY – Estimating the Prevalence of Orphan Diseases2017-07-18T19:40:24+00:00

Pharma Forecasting Case Study – Valuing the Impact of Development Delays

2017-07-18T19:41:48+00:00

A multinational pharmaceutical firm asked Ozmosi to provide forecasts to assess the market impact of delays in delivering new formulation and packaging for an existing product. A planned reformulation seen as necessary to preserving market share had been delayed for fifteen months, and the management team was concerned about the effect that delay would have on the company’s market share, and on the continued profitability of the drug. There was even some doubt from management that a reformulation was still cost-effective after such a delay. Ozmosi had to work with existing forecast models, modifying these to reflect recent market research findings [...]

Pharma Forecasting Case Study – Valuing the Impact of Development Delays2017-07-18T19:41:48+00:00
Go to Top